A1ln34 Stock Price To Earnings To Growth

A1LN34 Stock  BRL 73.85  0.35  0.48%   
A1LN34 fundamentals help investors to digest information that contributes to A1LN34's financial success or failures. It also enables traders to predict the movement of A1LN34 Stock. The fundamental analysis module provides a way to measure A1LN34's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to A1LN34 stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

A1LN34 Company Price To Earnings To Growth Analysis

A1LN34's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Based on the latest financial disclosure, A1LN34 has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earnings to growth for all Brazil stocks is 100.0% higher than that of the company.

A1LN34 Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses A1LN34's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of A1LN34 could also be used in its relative valuation, which is a method of valuing A1LN34 by comparing valuation metrics of similar companies.
A1LN34 is currently under evaluation in price to earnings to growth category among its peers.

A1LN34 Fundamentals

About A1LN34 Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze A1LN34's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of A1LN34 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of A1LN34 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in A1LN34 Stock

A1LN34 financial ratios help investors to determine whether A1LN34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in A1LN34 with respect to the benefits of owning A1LN34 security.